Aktive Überwachung beim Nierenzellkarzinom

Autor:	M. Siebels, C. Doehn, U. Witzsch
Rok vydání:	2012
Předmět:	medicine.medical_specialty Pathology medicine.diagnostic_test business.industry Urology medicine.medical_treatment Cryoablation urologic and male genital diseases medicine.disease Nephrectomy Metastasis Renal cell carcinoma Biopsy medicine Carcinoma Radiology business Kidney cancer Grading (tumors)
Zdroj:	Aktuelle Urologie. 43:243-249
ISSN:	1438-8820 0001-7868
DOI:	10.1055/s-0032-1321828
Popis:	The incidence of renal cell carcinoma (RCC) and especially that of small RCCs is increasing. However, not all tumours are malignant and not all malignant tumours are RCCs. Although partial nephrectomy is the therapeutic standard of care, an increasing number of patients is being treated with cryoablation, radiofrequency ablation, or active surveillance. The latter options require a pretherapeutic tumour biopsy. Approximately 85% of all biopsies can distinguish benign from malignant tumours. In the case of a RCC, histological subtype and grading are correctly diagnosed in 85% and 65%, respectively. However, tumour growth and metastasis in patients undergoing active surveillance cannot be predicted. A later tumour growth is the main trigger to change to active therapy. In this paper the results of tumour biopsy and active surveillance of patients with a renal mass are presented.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d821d1dda7fdee4c05a9bbc67925da2f https://doi.org/10.1055/s-0032-1321828 Zobrazit plný text záznamu